Of note, two of those patients suffered from diabetes (40% of all diabetic patients in this cohort), a sub-cohort maybe especially prone to post-therapeutic hyperkalemia due to reduced sensitivity to endogenous insulin. This evidence concerns the gene INS and Hyperkalemia.